EBOS Group Limited/Announcement
EBOS Group Limited logo

Sybos partial sell-down

Substantial Holder Notice18 November 2019EBOHealthcare

EBOS Group Limited. NZBN 9429031998840
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. PO Box 7300, Melbourne, Victoria 8004, Australia.

Phone: +61 3 9918 5555, Fax: +61 3 9918 5599.

www.ebosgroup.com





18 November 2019


NZX / ASX Code: EBO



Sybos partial sell-down

EBOS Group Limited (NZX, ASX: EBO) (EBOS) has been advised that its largest shareholder Sybos

Holdings Pte Limited (Sybos), which holds 60,525,721 ordinary shares in EBOS (37.33%), has today

entered into an underwriting agreement with a financial institution to sell a portion of its shares

(Sale).

To ensure an equally informed market, EBOS advises that it considers that it is in compliance with

its continuous disclosure and financial reporting obligations. EBOS considers, having made enquiry,

that it does not currently possess any information that it is withholding from disclosure under an

exception, nor is it relying on any waiver, under either the NZX Listing Rules or the ASX Listing

Rules. EBOS understands that Sybos will sell the relevant shares without regulated disclosure under

the Australian Corporations Act 2001 or the New Zealand Financial Markets Conduct Act 2013.

Yours faithfully


Janelle Cain

General Counsel

EBOS Group Limited


Important notice

This announcement has been prepared by EBOS on the basis of information available to it at the

time of preparation, and from information provided by Sybos. No representation or warranty,

express or implied, is made or given by or on behalf of EBOS, any of its directors, or any other

person about the accuracy, completeness or fairness of the information contained in this notice and

to the maximum extent permitted by law, no responsibility or liability is accepted by any of them for

that information or for any errors, omissions, statements (negligent or otherwise) or for any

communication written or otherwise, contained or referred to in this notice. This notice is not for

release to US wire services or for distribution in the United States


To the extent that the Sale is being made in reliance upon the exclusion in clause 19 of Schedule 1 to

the Financial Markets Conduct Act 2013, this announcement is made under clause 20(1)(a) of

Schedule 8 to Financial Markets Conduct Regulations 2014 and section 708A(5)(e) of the Australian

Corporations Act 2001 as modified by ASIC Instrument 2016/81 and EBOS has confirmed the

information that would be required for a formal cleansing notice under the relevant Australian and

New Zealand legislation.

2

For further information, please contact:

Shaun Hughes

CFO, EBOS Group Ltd

+61 428 833 981



About EBOS:


EBOS Group Limited is the largest and most diversified Australasian marketer, wholesaler and

distributor of healthcare, medical and pharmaceutical products. It is also a leading marketer and

distributor of recognised consumer products and animal care brands.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.